DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.
The period considered for the human biobanking applications market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia- Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 157 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
What Are Sustainability Metrics in A Cancer-Oriented Biobank?
Caladrius Biosciences, Inc. Finalizes Corporate Name Change From Neostem, Inc.
Lonza, The World’s Leading Developer and Manufacturer Of Cells For Regenerative Medicine Therapeutics, and Nikon Corporation Announced Today An Exclusive Collaboration in The Field Of Cell and Gene Therapy Manufacturing in Japan.
Cytomedix Announces Corporate Name Change To Nuo Therapeutics, Inc.
Lifecell Corporation and Novadaq Technologies Agree To Early Transition Of Spy Elite® Intraoperativeperfusion Assessment System Business Back To Novadaq.
Cryoxtract Enters Into Distribution Agreements With Cambridge Bioscience Ltd. and Lbd Life Sciences Ltd.
Biobanking Viable Immune Cells - Transportation Matters!
Dried Blood Spots: New Applications For Biobanking?